美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Braveheart Bio

26.64

-0.6100-2.24%

盤後：26.640.00000.00%19:30 EDT

成交量：28.36萬

成交額：776.76萬

市值：23.99億

市盈率：-1.81

高：28.74

開：28.12

低：26.54

收：27.25

52周最高：32.00

52周最低：24.31

股本：9,003.90萬

流通股本：2,583.17萬

量比：0.78

換手率：1.10%

股息：- -

股息率：- -

每股收益(TTM):-14.6845

每股收益(LYR):-17.2003

淨資產收益率：--

總資產收益率：--

市淨率：-25.01

市盈率(LYR):-1.55

資料載入中...

總覽公司新聞公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞

美國研究綜述-Adobe、Braveheart Bio、CACI International

新聞稿：Braveheart Bio 宣佈擴大規模首次公開募股完成，並完全行使承銷商超額配股權

市場快訊——美股行情動態-Braveheart Bio、Paysign、Hertz Global

異動解讀 | IPO首日表現強勁，Braveheart Bio盤中大漲67.78%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/BRVE"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BRVE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BRVE\",,,,,undefined,":{"symbol":"BRVE","market":"US","secType":"STK","nameCN":"Braveheart Bio","latestPrice":26.64,"timestamp":1789156800000,"preClose":27.25,"halted":0,"volume":283591,"hourTrading":{"tag":"盘后","latestPrice":26.64,"preClose":26.64,"latestTime":"19:30 EDT","volume":3375,"amount":89905.66,"timestamp":1789169407648,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.02238532110091741,"floatShares":25831738,"shares":90039000,"eps":-14.684527,"marketStatus":"休市中","change":-0.61,"latestTime":"09-11 16:00:00 EDT","open":28.12,"high":28.74,"low":26.54,"amount":7767601.163013999,"amplitude":0.080734,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-14.684527,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"listingDate":1785988800000,"exchange":"NASDAQ","adjPreClose":27.25,"postHourTrading":{"tag":"盘后","latestPrice":26.64,"preClose":26.64,"latestTime":"19:30 EDT","volume":3375,"amount":89905.66,"timestamp":1789169407648,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7839558186905717},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BRVE\",,,,,undefined,":{"symbol":"BRVE","floatShares":25831738,"roa":"--","roe":"--","lyrEps":-17.200311,"volumeRatio":0.7839558186905717,"shares":90039000,"dividePrice":0,"high":28.74,"amplitude":0.080734,"preClose":27.25,"low":26.54,"week52Low":24.305,"pbRate":"-25.01","week52High":32,"institutionHeld":0,"latestPrice":26.64,"eps":-14.684527,"divideRate":0,"volume":283591,"delay":0,"ttmEps":-14.684527,"open":28.12,"prevYearClose":18,"prevWeekClose":26.74,"prevMonthClose":25.5,"prevQuarterClose":18,"fiveDayClose":26.27,"twentyDayClose":25.97,"sixtyDayClose":18},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BRVE\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BRVE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BRVE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":4,"updateTime":1788926400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BRVE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BRVE","date":"2026-09-11","current":-1.814154,"percent":0.923077,"low":-23.993466,"twenty":-22.185958,"median":-21.618113,"eighty":-20.469626,"high":-12.297967,"avg":-20.979317,"sd":2.525661,"marketCap":1748603206},"quantilePoints":[{"date":"2026-08-07","current":-22.904964,"twenty":-19.277064,"median":-13.835213,"eighty":-12.912865,"marketCap":1837733965},{"date":"2026-08-14","current":-20.770344,"twenty":-22.55018,"median":-20.842324,"eighty":-16.302149,"marketCap":1666466982},{"date":"2026-08-21","current":-21.930028,"twenty":-22.591769,"median":-21.618113,"eighty":-20.309669,"marketCap":1759511923},{"date":"2026-08-28","current":-22.281932,"twenty":-22.249941,"median":-22.006007,"eighty":-20.827928,"marketCap":1787746250},{"date":"2026-09-04","current":-21.010278,"twenty":-22.169963,"median":-21.930028,"eighty":-20.827928,"marketCap":1685717659},{"date":"2026-09-11","current":-18.437402,"twenty":-22.185958,"median":-21.618113,"eighty":-20.469626,"marketCap":1748603206}],"updateTime":1789313925472},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BRVE\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663002003","title":"美國研究綜述-Adobe、Braveheart Bio、CACI International","url":"https://stock-news.laohu8.com/highlight/detail?id=2663002003","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663002003?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 15:24","pubTimestamp":1788161080,"startTime":"0","endTime":"0","summary":"美国研究综述-Adobe、Braveheart Bio、CACI International路透8月31日-周一，华尔街证券分析师上调了包括Adobe、Braveheart Bio和CACI International在内的几家美国上市公司的评级和目标股价。重点摘要* Adobe IncADBE.O：杰富瑞将目标价从230美元上调至285美元* Braveheart Bio, Inc.BRVE.O：杰富瑞首次覆盖该股，给予“买入”评级* CACI International IncCACI.N：TD Cowen将目标价从550美元上调至700美元以下是路透周一报道的关于美国公司的研究动态摘要。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL4S44S0JC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B66KJ199.SGD","LU0006306889.USD","BK4554","LU1261432733.SGD","LU1267930730.SGD","LU0472753341.HKD","LU0719512351.SGD","LU0792757196.USD","LU2095319765.USD","LU1119994496.HKD","LU2125154778.USD","LU0106261372.USD","LU0708995401.HKD","BRCC","SG9999004303.SGD","LU0256863902.USD","IE00B7SZL793.SGD","LU0256863811.USD","LU1366333091.USD","PTGX","LU1720051108.HKD","LU0861579265.USD","LU1035773651.USD","LU2125154935.USD","LU0980610538.SGD","LU0868494617.USD","LU1069347547.HKD","ADBU","BK4123","LU2458330169.SGD","ADBE","IE0031619046.USD","LU0011850046.USD","BK4566","LU0109391861.USD","LU0314104364.USD","LU0417517546.SGD","LU0787776722.HKD","LU0154245756.USD","LU0342679015.USD","LU1803068979.SGD","LU1633808545.USD","BK4533","LU1267930813.SGD","LU1712237335.SGD","LU0511384066.AUD","BK4567","LU0689626769.HKD","LU0061474960.USD","BK4581","LU0109392836.USD","BK4097","BK4550","LU0154245673.USD","LU2089283258.USD","LU0345774391.USD","SG9999015945.SGD","LU2357305700.SGD","LU0648001328.SGD","LU0320765059.SGD","BRVE","LU0942090050.USD","LU1201861249.SGD","LU1169589451.USD","LU1548497426.USD","IE00B1BXHZ80.USD","LU0683600562.USD","LU1623119135.USD","BK4114","LU0971096721.USD","LU2458330243.SGD","BK4007","SG9999015986.USD","LU0234570918.USD","LU0072461881.USD","LU2089284900.SGD","LU0130517989.USD","LU0965509101.SGD","SGXZ23171101.USD","LU0006061336.USD","LU2023250504.SGD","LU0054578231.USD","ATI","LU0889566641.SGD","LU2237438978.USD","LU0069063385.USD","BK4528","LU1084165304.USD","LU1720051017.SGD","LU1878469433.USD","LU0234572021.USD","LU0963586101.USD","LU2106854487.HKD","LU0314106906.USD","BK4023","SPAM","LU1169590202.USD","IE00B19Z4B17.USD","LU0738911758.USD","BK4187","LU0345774631.USD","LU1506573853.SGD","LU0661504455.SGD","BCDF","LU2247934214.USD","LU2236285917.USD","LU0289739343.SGD","BK4112","BK4588","LU0198837287.USD","LU2065731478.USD","LU2023251221.USD","LU0348723411.USD","IE00B5TLWC47.USD","BK4504","LU0557290698.USD","LU0158827948.USD","PSWD","LU2210149790.SGD","RBRK","LU1235294995.USD","LU1974910355.USD","IE00BQXX3C00.GBP","LU0889565833.HKD","LU0477156953.USD","LU1363072403.SGD","SGXZ99366536.SGD","IE00B19Z9505.USD","LU0130102774.USD","BK4212","BK4602","SGXZ51526630.SGD","LU0957791311.USD","LU1815333072.USD","DLTR","LU0124676726.USD","LU2360032135.SGD","LU0965509010.AUD","LU0672654240.SGD","BK4006","IE0009356076.USD","LU0162691827.USD","LU2237957811.SGD","LU2237957902.USD","SG9999015952.SGD","LU1917777945.USD","LU0082616367.USD","ADBG","IE00BYQQ9H92.USD","ICE","BK4585","LU1823568750.SGD","LU1674673691.USD","SG9999000418.SGD","LU2023250843.SGD","IE00BFXG0V08.USD","BK4613","LU0157215616.USD","LU0081259029.USD","LU1674673428.USD","LU1691799644.USD","BK4139","LU1778281490.HKD","SGXZ81514606.USD","LU1046421795.USD","IE00BQXX3F31.USD","LU0868494708.USD","LU0965509283.SGD","LU2286300806.USD","HON","IE0034235188.USD","LU0170899867.USD","SG9999001424.SGD","BK4543","LU2317271919.USD","LU2210150020.SGD","BK4534","LU0390134368.USD","BK4527","LU0289961442.SGD","RSPS","LU0057025933.USD","LU0154236417.USD","BK4206","GB00BDT5M118.USD","LU1153585028.USD","LU0949170772.SGD","HONG","BK4592","SG9999015978.USD","IE00BQXX3D17.EUR","BK4155","CACI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171302218","title":"新聞稿：Braveheart Bio 宣佈擴大規模首次公開募股完成，並完全行使承銷商超額配股權","url":"https://stock-news.laohu8.com/highlight/detail?id=1171302218","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171302218?lang=zh_tw&edition=fundamental","pubTime":"2026-08-08 04:09","pubTimestamp":1786133340,"startTime":"0","endTime":"0","summary":"旧金山，2026年8月7日——Braveheart Bio, Inc.是一家临床阶段的生物制药公司，致力于开发针对肥厚型心肌病及其他严重心血管疾病的下一代疗法。该公司今日宣布，其扩大的首次公开募股已完成。此次发行总计24,437,500股普通股，每股发行价为18.00美元，且承销商已完全行使了购买额外3,187,500股的选择权。所有普通股均由Braveheart Bio提供。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0511384066.AUD","CMI","LU2463526074.USD","BK4585","LU0057025933.USD","BK4149","LU0154245673.USD","BK4533","BRVE","LU0289739343.SGD","IE000M9KFDE8.USD","BK4567","HCM","BK4531","IPOS","LU0124676726.USD","LU0069063385.USD","LU0203347892.USD","LU0689626769.HKD","MADE","LU0203345920.USD","LU0289961442.SGD","BK4588","BK4007","LU0472753341.HKD","LU0154245756.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657597666","title":"市場快訊——美股行情動態-Braveheart Bio、Paysign、Hertz Global","url":"https://stock-news.laohu8.com/highlight/detail?id=2657597666","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657597666?lang=zh_tw&edition=fundamental","pubTime":"2026-08-07 01:45","pubTimestamp":1786038322,"startTime":"0","endTime":"0","summary":".N美国东部时间13:30，道琼斯工业平均指数.DJI下跌0.85%，报53,886.07点；标普500指数.SPX下跌0.28%，报7,701.81点；纳斯达克综合指数.IXIC下跌0.10%，报26,337.82点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL4T44328R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTRS","PZZA","SRRK","FOUR","LNG","PH","MAC","MTSI","NVAX","HWM","GBFH","SNDK","UWMC","IOVA","RL","RXO","WDC","RCBC","SITM","CHYM","PAYC","DDOG","KDP","APP","HTZ","SRE","CEG","BRVE","TPG","ZTS","SMR","FIG","RDVT","VCTR","BLLN","U","KVUE","BDX","MRNA","ROOT","CELH","FISV","PRMB","SPCX","LCLN","INSM","FRT","EPAM"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1138238457","title":"異動解讀 | IPO首日表現強勁，Braveheart Bio盤中大漲67.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=1138238457","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138238457?lang=zh_tw&edition=fundamental","pubTime":"2026-08-07 00:52","pubTimestamp":1786035174,"startTime":"0","endTime":"0","summary":"心血管药物开发商Braveheart Bio今日在纳斯达克首日上市交易，盘中股价大涨67.78%，引发市场广泛关注。Braveheart Bio总部位于加州旧金山，是一家处于临床后期的生物制药公司，专注于开发肥厚型心肌病及其他严重心血管疾病的创新疗法。在2026年生物科技IPO热潮的背景下，Braveheart Bio的成功上市进一步彰显了市场对创新药企的强劲信心。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BRVE"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":9,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BRVE\",params:#limit:6,delay:false,,,undefined,":[]}}